Vita Life Sciences Limited · ASX:VLS

Vita Life Sciences — Shareholder Meeting (May 2012)

23 slides from Vita Life Sciences's shareholder meeting presentation, May 16, 2012

  1. Slide 1: AGM Presentation 16 May 2012

    For personal use only 16 May 2012 ASX Code: VSC

  2. Slide 2: Chairman's Welcome Address

    Chairman’s Welcome Address

  3. Slide 3: Chairman's Address

    For personal use only 1 Chairman 1. Chairman’s s Welcome Address 2. Managing Director’s Review 3. Ordinary & Special Resolutions 4. Question & Answer Time

  4. Slide 4: Managing Director's Review

    Managing Directors Review

  5. Slide 5: Awards

    For personal use only MLM Company awarded: “The 7th Asia “Th A i PPacific ifi SSuper E Excellence ll B Brand d 2011 for Leadership Excellence in Brand Development and Management Organization ” awarded: “The The 2011 Asia Pacific BrandLaureate for Best Brands in Wellness – Supplements”

  6. Slide 6: 2011 Highlights

    For personal use only  Solid sales growth of 15.6%  Record PBT of $1.40 million  Strong balance sheet and no debt – Shareholders’ funds of $8.96 million  Maintained dividend trend of 0.5 cents per share  The Th Group’s G ’ brands b d continue ti to t build b ild th their i presence in 8 countri

  7. Slide 7: Australia, Malaysia and Singapore results

    Australia For personal use only  14.1% sales growth y-o-y basis  Herbs of Gold Products sold in more than 750 health foods stores  Vita Science sold into around 150 pharmacies, with sales growth of 46.9% over 2010 Malaysia  20.4% sales growth yy-o-y o y basis in established business local curren

  8. Slide 8: Sales contribution by country

    For personal use only 2010 2011 Singapore Singapore 16% 19% Australia Australia 45% 45% Others Others 2% 2% Malaysia M l i Malaysia 37% 34%  Sales S l growth h on y-o-y basis b ffor Australia, l Malaysia l and d Singapore were 14.1%, 20.4% and 3.0% respectively (in local currencies)  Australia rem

  9. Slide 9: Thailand, MLM, China, Vietnam and Indonesia

    For personal use only Thailand  58.5% sales growth and profitable  Products P d t reach h in i more than th 2,000 2 000 pharmaceutical h ti l outlets Multi-Level Multi Level Marketing in Malaysia  Contributed 9.2% of Group sales with sales growth of 66.8%  Lower loss in 2011 China  Sales grew b

  10. Slide 10: Revenue

    For personal use only Revenue ‐ #039;m 24 30 24.30  2011 Sales ggrew by y 15.6% despite the stronger A$ 21.00 17.70  New Business units sales are small but gaining traction, contributed 11.0% in 2011 (2010: 7.2%, 2009:2.4%)  MLM business unit now contributes 9.2% 9 2% (6.7% (6 7% in 2010) 2009 2010

  11. Slide 11: Population coverage of products

    For personal use only Present: Products sold in 8 major countries Total population of 8 countries:1,812 million World’s World s population (April 2012) : 6,974 million Coverage : 26% In 2005: Products sold in 3 major countries Coverage (at current population): 0.8%

  12. Slide 12: World Economic Outlook, April 2012

    World Economic Outlook, April 2012 Country/ Population 2010 2011 2012 2013 2014 2015 2016 2017 (million) GDP pper 8 418 8,418 9 700 9,700 10 467 10,467 11 099 11,099 11 803 11,803 12 551 12,551 13 347 13,347 14 194 14,194 Malaysia capital (US$) For personal use only (28.8) Inflation (%) 1.7 3.2 2.7

  13. Slide 13: Financial summary

    For personal use only Year ended 31 December 2010 2011 A#039;million $ A#039;million $ Revenue 20.99 24.27 Profit Before Tax 4.92 1.57 Profit After Tax 4.46 1.21 Shareholders' Funds 8.13 8.96 Cash 0.46 3.63 Borrowings (1.81) -

  14. Slide 14: Income Statement

    For personal use only Income Statement ($ million) 2010 2011 % Change EBIT 4.90 1.57 <100% (Less)/Add: Extraordinary items Net External PAN (income)/costs (4.10) - 100% Underlying EBIT 0 80 0.80 1 57 1.57 95% Interest expense (0.29) (0.16) -43% Underlying y g net p profit bef tax 0.51 1.40 174% Inco

  15. Slide 15: Balance Sheet

    For personal use only Balance Sheet ($ m) 2010 2011 Current assets 12.23 10.93  Strong balance sheet with Non-current assets 2.29 2.42 no debt Total assets 14.51 13.35  Net assets increased to Current liabilities (6.38) (4.37) $8.9m, tripled since 2007 Non-current liabilities (0.01) (0.03)  40% o

  16. Slide 16: Outlook

    For personal use only  Established Business Units to perform consistently with stable growth  New Business units expected to continue extending Group’s expansion strategy gy in China,, Malaysia y and Thailand  Continued focus on sales, market share, profitability and expenditure control  Managem

  17. Slide 17: Current trading and forecast

    For personal use only  Unaudited management reports showed record first quarter sales  Exceeded the expected 15% sales growth as forecast in the 2011 Financial Statements  Expect this trend to continue throughout the year  Sales to June 2012 forecast to exceed the corresponding period in 2011 by

  18. Slide 18: Dividend Payout Ratio

    For personal use only Dividend Payout Ratio  Dividends of 0.5 cents per share 24% paid for financial year 2011 and 2010  Dividend payout ratio of 24% PAT with 76% reinvested in the operations  Strength of earnings and positive 6% operational cash may allow interim and annual dividend for 2012 0%

  19. Slide 19: Agenda

    For personal use only 1. Chairman Chairman’s s Address 2. Managing Director’s Review 3. Ordinary & Special Resolutions 4 Question 4. Q ti & Answer A Ti Time

  20. Slide 20: Resolutions

    For personal use only 1. Remuneration Report 2. Election of Director – John Sharman 3. Election of Director – Henry Townsing 4. Share buy-back 5 Long 5. L Term T Incentive I ti Plan Pl – Grant G t off a limited recourse loan to Managing Director

  21. Slide 21: Proxy voting results

    For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST ABSTAIN TOTALS DISCRETION 1) Adoption of the Remuneration 37,082,696 33,442 2,410,095 5,021 39,531,254 Report 2) Election of Director (Mr J 39,243.038 - 283,195 5,021 39,531,254 Sharman) 3) Election of Director (Mr H 39 056 025 39,056,025 -

  22. Slide 22: Agenda

    For personal use only 1. Chairman Chairman’s s Address 2. Managing Director’s Review 3. Ordinary & Special Resolutions 4 Question 4. Q ti & Answer A Ti Time

  23. Slide 23: Thank You

    For personal use only Th k You Thank Y 16 May 2012

Vita Life Sciences — Shareholder Meeting (May 2012) on 6ix